Live Breaking News & Updates on Sutro biopharma inc

Stay informed with the latest breaking news from Sutro biopharma inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sutro biopharma inc and stay connected to the pulse of your community

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Rating of "Buy" by Analysts

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Rating of "Buy" by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nicki-vasquez , Piper-sandler , Sutro-biopharma , Sutro-biopharma-inc , Nasdaq , Securities-exchange-commission , Sectoral-asset-management-inc , Vontobel-holding-ltd , Opaleye-management-inc , Get-free-report , Marketbeat-ratings , Biopharma-trading-down

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $12.57 Average Price Target from Brokerages

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $12.57 Average Price Target from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nicki-vasquez , Sutro-biopharma , Piper-sandler , Vanguard-group-inc , Exome-asset-management , Barclays-plc , Nuveen-asset-management , Nasdaq , Virtu-financial , Sutro-biopharma-inc , Securities-exchange-commission , Get-free-report

Truist Financial Cuts Sutro Biopharma (NASDAQ:STRO) Price Target to $18.00

Truist Financial Cuts Sutro Biopharma (NASDAQ:STRO) Price Target to $18.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Sutro-biopharma , Nicki-vasquez , Principal-financial-group-inc , American-century-companies-inc , Prudential-financial-inc , Manufacturers-life-insurance-company , Sutro-biopharma-inc , American-international-group-inc , Free-report , Truist-financial

Ipsen And Sutro Partnering On ADCs Is A Deal Offering Opportunities For Investors (IPSEY)

Ipsen And Sutro Partnering On ADCs Is A Deal Offering Opportunities For Investors (IPSEY)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Denmark , Japan , China , United-states , Canada , Paris , France-general- , France , Danish , American , Luveltamab-tazevibulin , Sutro-biopharma

Ipsen enters ADC space licensing Sutro's ROR1 drug STRO-003

Jumping in for the first time to the hot antibody-drug conjugate (ADC) space, Paris-based Ipsen SA pulled in exclusive global rights to a preclinical ROR1-targeting candidate from Sutro Biopharma Inc. in a deal worth up to $900 million.

Sutro-biopharma-inc , Paris-based-ipsen , Sutro-biopharma ,

Sutro Biopharma (NASDAQ:STRO) Receives Overweight Rating from Piper Sandler

Sutro Biopharma (NASDAQ:STRO) Receives Overweight Rating from Piper Sandler
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Swiss , Sutro-biopharma , Nicki-vasquez , Piper-sandler , Metlife-investment-management , Sutro-biopharma-company-profile , Blackrock-inc , Securities-exchange-commission , Jpmorgan-chase-co , Swiss-national-bank , Healthcare-of-ontario-pension-plan-trust-fund

Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors

Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completing the final stages of pre-clinical developmentSTRO-003 targets ROR1, a...

South-san-francisco , California , United-states , Paris , France-general- , France , San-diego , American , Emily-white , Amy-wolf , Jess-smith , Sutro-biopharma

Ipsen and Sutro Biopharma announce exclusive global

Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completing the final stages of...

San-diego , California , United-states , Paris , France-general- , France , South-san-francisco , American , Nicolas-bogler , Ipsen-euronext , Amy-wolf , Jane-chung

Ipsen Pharma: Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors

Ipsen Pharma: Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , France , Paris , France-general- , American , Amy-wolf , Jess-smith , Jane-chung , Nicolas-bogler , Ipsen-euronext

Sutro Biopharma Inc. (STRO) Prices 14.48M Share Offering at $5.18/sh

Sutro Biopharma Inc. (STRO) Prices 14.48M Share Offering at $5.18/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

North-carolina , United-states , Charlotte , Nasdaq , Exchange-commission , Sutro-biopharma-inc , Prospectus-department , Sutro-biopharma , Bofa-securities , Tryon-street ,